Secant Medical to Present the Prevention of Device Implant Infections at MD&M Philadelphia
By Business Wire News
By Business Wire News
Jeremy Harris, technical director at Secant Medical, will present “Medical Materials to the Rescue: Leveraging Polymer Innovation to Prevent Device Implant Infections” at the MD&M Philadelphia Conference during the New Materials/Medtech Polymers session on October 8th from 11:15-11:45 a.m. The presentation will address the use of polymers to prevent infections in medical device implants.
“Utilizing polymers in medical device development has the potential to reduce or even prevent a device-related infection,” said Harris. “One polymer technology platform we have been studying, poly(glycerol sebacate) (PGS) is a surface eroding, resorbable polymer which has exhibited antimicrobial activity that may help prevent secondary site infections when used as a device coating.”
Harris will discuss the problem with bacteria, using antimicrobial polymers and antibacterial agents, and the benefits this technology offers to prevent infection. The MD&M Philadelphia Conference takes place October 7-8 in Philadelphia at the Pennsylvania Convention Center.
Presentation: Medical Materials to the Rescue: Leveraging Polymer Innovation to Prevent Device Implant Infections
When: Thursday, October 8, 2015 11:15 am – 11:45 a.m.
Where: Pennsylvania Convention Center, Philadelphia, PA
About MD&M Philadelphia: MD&M Philadelphia brings together the regions Medtech Community to delve into the latest challenges and opportunities that are impacting the industry. The conference will feature a multi-track agenda focusing on five areas of interest including, innovations in 3D printing, packaging design that sells, human centered design, new materials/Medtech polymers, and medical device innovation.
About Secant Medical: Secant Medical designs and manufactures biomedical textiles and advanced biomaterials for medical devices and pharmaceuticals. Employing medical fabric engineering technologies, we blend polymeric, metallic and resorbable biomaterials to create custom, high-performance structures that are used in the cardiovascular, general surgery, neurovascular, orthopedic and regenerative medicine fields. Built on a 70-year history, we’re committed to the future of biomaterials and their role in the healing process and are actively engaged in research partnerships to advance next-generation biomaterial development. Secant Medical is a business unit of Fenner PLC, a worldwide leader in reinforced polymer engineering headquartered in Yorkshire, England. For more information, visit www.secantmedical.com.
Nara Burke, 215-257-8680 x130